1-2 of 2
Mehmood Husssain Qazi, PhD
Close
Sort by
Journal Articles

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

Zafar Iqbal, MPhil PhDPost-doc., Afia Muhammad Akram, Tanveer Akhtar, PhD, Aamer Aleem, MBBS FRCP, Muhammad Farooq Sabar, PhD, Zeba Aziz, MD MBBS, Nadia Sajid, Mahmood Rasool, PhD, Muhammad Asif, Mehmood Husssain Qazi, PhD, Saleh Oraibi, PhD, Ammara T Gill, MBBS ABIM, Khalid Al Jamaan, MDFRCPC, Mudassar Iqbal, MDMS, Ahmad Mukhtar Khalid
Journal: Blood
Blood (2016) 128 (22): 3089.
https://doi.org/10.1182/blood.V128.22.3089.3089
Published: 2016
Journal Articles

Detection of Compound BCR-ABL Mutations in TKI Resistant CML Patients Including a Novel K245N Mutation Associated with Primary Nilotinib Resistance By Employing a Newly Developed Cost Effective BCR-ABL Sequencing Protocol

Zafar Iqbal, MPhil PhDPost-Doctorate, Tanveer Akhtar, PhDPost-Doctorate, Afia M Akram, Muhammad Khalid, MS PhD, Ijaz Husssain Shah, MBBS FCPS, Aamir Aleem, MBBS MRCP FRCPath, Muhammad Khalid, MBBS FCPS, Javed Iqbal, MBBS FCPS, Zeba Aziz, MD MBBS, Muhammad Absar, MSc, Jamil Amjad Hashmi, PhDPost-Doctorate, Mehmood Husssain Qazi, PhD, Ahmad Mukhtar Khalid, MSc, PhD, Muhammad Farooq Sabar, PhD, Sajjad Karim, PhD, Mahmood Rasool, MSc PhD, Aamir Mahmood, PhD, Ammara Tariq Gill, MD, Giuseppe Saglio, MD, Mudassar Iqbal, MD
Journal: Blood
Blood (2014) 124 (21): 1810.
https://doi.org/10.1182/blood.V124.21.1810.1810
Published: 2014